InsidersTradesSigma
Browse the complete record of transactions filed by Guido Oelkers, Chairman & CEO. Officer active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 3 reports have been logged. History available since 27 October 2025. The latest transaction was disclosed on 31 October 2025 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
3 of 3 declarations
Guido Oelkers is the CEO of Swedish Orphan Biovitrum AB (publ). He is responsible for managing the company's operations, which specializes in orphan drugs. His role is essential for achieving the company's strategic objectives.